Omega Fund VI, L.P.

Omega Fund VI, L.P. serves as a 10% owner of Lexeo Therapeutics, Inc. and has been active in recent SEC Form 4 filings. On November 9, 2023, the firm reported a substantial purchase of approximately $5.0 million in Lexeo Therapeutics (LXEO), marking a significant move in their investment strategy. This profile details their trading activity, highlighting their focus on the manufacturing sector and the implications of their recent investment decisions.